Analyst consensus rating
Korro Bio Analyst Rating: Strong Buy
KRRO is rated Strong Buy by 10 analysts with a $20.20 target. As of 2026-08-21.
Direct answer
Korro Bio's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $20.20.
Forecast evidence checked August 21, 2026.
Get free Korro Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.23
- Average price target
- $20.20
- High price target
- $30.00
- Low price target
- $10.00
- Low target gap
- -24.4%
- Target upside
- +52.7%
- High target gap
- +126.8%
- Target range width
- 151.2%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Korro Bio?
Korro Bio has a verified Strong Buy consensus. The same dataset has an average price target of $20.20.
How far are Korro Bio's low and high targets from the recorded price?
The low target implies -24.4%, while the high target implies +126.8%.
How many analysts are included in Korro Bio's consensus?
The verified consensus includes 10 analysts.
How is Korro Bio's target upside or downside calculated?
The average target of $20.20 is divided by the recorded price of $13.23, then one is subtracted to produce +52.7%. This does not guarantee a future return.
When was Korro Bio's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.